 | Up a level |
Poeppel, T D; Boy, Christian; Bockisch, A; Kotzerke, J; Buchmann, I; Ezziddin, S; Scheidhauer, K; Krause, B J; Schmidt, D; Amthauer, H; Rösch, F; Nagarajah, J; Führer, D; Lahner, H; Pöpperl, G; Hörsch, D; Walter, Martin Alexander; Baum, R P (2015). Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1). Nuklearmedizin / Nuclear medicine, 54(1), pp. 1-11. Schattauer
Kaemmerer, D; Posorski, N; von Eggeling, F; Ernst, G; Hörsch, D; Baum, R P; Prasad, V; Langer, Rupert; Esposito, I; Klöppel, G; Sehner, S; Knösel, T; Hommann, M (2014). The search for the primary tumor in metastasized gastroenteropancreatic neuroendocrine neoplasm. Clinical & experimental metastasis, 31(7), pp. 817-827. Springer 10.1007/s10585-014-9672-3
Antunes, P; Ginj, M; Zhang, H; Waser, B; Baum, R P; Reubi, J. C.; Maecke, H (2007). Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? European journal of nuclear medicine and molecular imaging, 34(7), pp. 982-93. Berlin: Springer 10.1007/s00259-006-0317-x
